NOF (4403) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Net sales rose 11.9% year-over-year to ¥55,110 million for the quarter ended June 30, 2024, with operating profit up 31.5% to ¥13,533 million and profit attributable to owners of parent up 22.6% to ¥11,047 million.
The company continued to execute its 2025 Mid-Term Management Plan, focusing on market expansion, new product development, productivity, safety, and CSR.
Financial highlights
Gross profit increased to ¥22,880 million from ¥19,225 million year-over-year; ordinary profit rose 23.8% to ¥15,160 million.
Basic earnings per share were ¥46.30, reflecting a 3-for-1 share split effective April 1, 2024.
Total assets reached ¥345,830 million, up ¥4,381 million from March 31, 2024; net assets increased to ¥271,604 million.
Cash and deposits increased by ¥543 million; inventories rose by ¥6,526 million; trade receivables decreased by ¥4,661 million.
Outlook and guidance
Full-year forecast remains unchanged: net sales of ¥232,000 million (+4.4% YoY), operating profit of ¥40,500 million (-3.9%), and profit attributable to owners of parent of ¥33,000 million (-2.9%).
Annual dividend forecast is ¥40.00 per share post-split.
Latest events from NOF
- Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 202613 Feb 2026 - Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 202618 Nov 2025 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 20255 Jun 2025